Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice

British Journal of Cancer, Published online: 16 February 2021; doi:10.1038/s41416-020-01255-zIntravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice

Source: British Journal of Cancer - February 16, 2021 Category: Cancer & Oncology Authors: Cornelius F. Waller Julia M öbius Adolfo Fuentes-Alburo Source Type: research